Aardvark Therapeutics, Inc. (AARD) has 5 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $395K. Most recent filing: Sept. 11, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 11, 2026 filed Sept. 10, 2026 | Sun Nelson See Remarks | −$394,957 | 76,754 | −68% | Yes | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 14, 2026 | Chi Jeffrey Director | $0 | 44,964 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 14, 2026 | Graf Susan E Director | $0 | 44,964 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 14, 2026 | Baynes Roy D. Director | $0 | 44,964 | 0% | No | |
|
|
||||||
| Aug. 21, 2026 filed Aug. 14, 2026 | Tong Victor Edward Jr Director | $0 | 44,964 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free